Jeff Yass’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$98.4K Buy
56,900
+2,300
+4% +$4.39K ﹤0.01% 12566
2026
Q2
$109K Buy
54,600
+1,900
+4% +$2.74K ﹤0.01% 12442
2026
Q1
$66.9K Buy
+52,700
New +$99.1K ﹤0.01% 12535
2025
Q2
– Sell
-16,000
Closed -$72.5K – 13075
2025
Q1
$72.5K Buy
16,000
+700
+5% +$3.7K ﹤0.01% 11727
2024
Q4
$108K Buy
+15,300
New +$122K ﹤0.01% 11280
2022
Q4
– Sell
-52,300
Closed -$507K – 12914
2022
Q3
$507K Buy
+52,300
New +$692K ﹤0.01% 8449
2021
Q4
– Sell
-29,900
Closed -$1.5M – 13420
2021
Q3
$1.5M Buy
29,900
+22,300
+293% +$1.22M ﹤0.01% 6494
2021
Q2
$422K Buy
7,600
+600
+9% +$32K ﹤0.01% 9987
2021
Q1
$327K Buy
+7,000
New +$339K ﹤0.01% 10420
2020
Q4
– Sell
-10,900
Closed -$399K – 11284
2020
Q3
$399K Sell
10,900
-11,200
-51% -$380K ﹤0.01% 8138
2020
Q2
$645K Buy
+22,100
New +$611K ﹤0.01% 6823

Other funds holding HCAT

Jeff Yass's HCAT Position: Q3 2026 in Review

Jeff Yass reduced its Health Catalyst (HCAT) stake by 10% in Q3 2026, selling an estimated $86.8K and leaving 391,783 shares worth $678K. The position accounts for ﹤0.01% of the portfolio, ranked #8941.

Jeff Yass first reported a position in HCAT in Q1 2020 and has held it in 23 quarters since. The position peaked at $1.09M in Q3 2024. 95 funds tracked by Wall St. Rank hold HCAT as of Q3 2026.

  • Jeff Yass held 391,783 shares of Health Catalyst worth $678K as of Q3 2026.
  • Jeff Yass sold 45,444 Health Catalyst shares in Q3 2026, an estimated $86.8K.
  • Health Catalyst made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #8941 holding.
  • Jeff Yass first reported a position in Health Catalyst in Q1 2020 and has held it in 23 quarters since.
  • Jeff Yass's Health Catalyst position peaked at $1.09M in Q3 2024.
  • 95 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.